Experimental Pharmacotherapy for COVID-19: The Latest Advances

Experimental Pharmacotherapy for COVID-19: The Latest Advances

Pasquale Pagliano,1 Giuliana Scarpati,2 Carmine Sellitto,3 Valeria Conti,3 Anna Maria Spera,1 Tiziana Ascione,4 Ornella Piazza,2 Amelia Filippelli3 1Department of Medicine, Surgery and Dentistry, “Scuola Medica Salernitana”, Unit of Infectious Diseases, University of Salerno, Bar...

Full description

Bibliographic Details
Main Authors:	Pagliano P, Scarpati G, Sellitto C, Conti V, Spera AM, Ascione T, Piazza O, Filippelli A
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-01-01
Series:	Journal of Experimental Pharmacology
Subjects:	sars-cov-2 ards remdesivir chloroquine steroids heparin
Online Access:	https://www.dovepress.com/experimental-pharmacotherapy-for-covid-19-the-latest-advances-peer-reviewed-fulltext-article-JEP

Similar Items

The Rationale for Potential Pharmacotherapy of COVID-19
by: Maha Saber-Ayad, et al.
Published: (2020-05-01)

A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking
by: Achal Mishra, et al.
Published: (2021-06-01)

Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants
by: Océane Delandre, et al.
Published: (2022-04-01)

Treatment Options for COVID-19: A Review
by: Mukarram Jamat Ali, et al.
Published: (2020-07-01)

Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
by: Frank M. P. van Haren, et al.
Published: (2020-07-01)

SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening
by: Cristina Adriana Dehelean, et al.
Published: (2020-07-01)

Measuring the energy for the molecular graphs of antiviral agents: Hydroxychloroquine, Chloroquine and Remdesivir
by: Muhammad Haroon Aftab, et al.
Published: (2024-01-01)

Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
by: Claudio Ortolani, et al.
Published: (2020-09-01)

How to follow-up a patient who received tocilizumab in severe COVID-19: a case report
by: Regina B. Podlasin, et al.
Published: (2020-08-01)

Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial
by: Sylvie Chevret, et al.
Published: (2023-08-01)

Progress in the Research and Development of Anti-COVID-19 Drugs
by: Lianzhou Huang, et al.
Published: (2020-07-01)

Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
by: Sultan Ayoub Meo, et al.
Published: (2020-10-01)

Gambaran Terapi Antivirus pada Pasien Covid-19 Di RSUP Dr. M. Djamil Padang Periode Maret-Agustus 2020
by: Rawzan Abdul Aziz, et al.
Published: (2023-09-01)

Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19
by: Jiansheng Huang, et al.
Published: (2020-04-01)

Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report
by: José A Gonzales-Zamora, et al.
Published: (2020-08-01)

Therapeutic Strategies in the Management of COVID-19
by: Rajashri R. Naik, et al.
Published: (2021-02-01)

Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19
by: Amrit Krishna Mitra
Published: (2020-12-01)

COVID-19: An Update about the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020-05-01)

COVID-19: A Brief Overview of the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020-04-01)

Benefits of Steroid Therapy in COVID-19 Patients with Different PaO<sub>2</sub>/FiO<sub>2</sub> Ratio at Admission
by: Serena Vita, et al.
Published: (2021-07-01)

COVID-19 Pharmacotherapy in Pregnancy: A Literature Review of Current Therapeutic Choices
by: Karolina Akinosoglou, et al.
Published: (2023-03-01)

Clinical Profile of Mortality and Treatment Profile of Survival in Patients with COVID-19 Pneumonia Admitted to Dubai Hospital
by: Rashid Nadeem, et al.
Published: (2021-06-01)

Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis
by: Massimo Franchini, et al.
Published: (2024-02-01)

Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection
by: Yu Ling Tan, et al.
Published: (2021-07-01)

Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)
by: Abhi Bhadra, et al.
Published: (2020-05-01)

Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
by: Xinni Xu, et al.
Published: (2020-05-01)

Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters Hospitals in the Punjab province of Pakistan
by: Zia Ul Mustafa, et al.
Published: (2022-03-01)

A study of effect of remdesivir on mortatlity and hospital stay of moderate to severe cases of COVID-19/ severe acute respiratory illness in North Karnataka region
by: Habibulla D. Attar, et al.
Published: (2021-07-01)

Clinical evolution and mortality of critically ill patients with SARS-CoV-2 pneumonia treated with remdesivir in an adult intensive care unit of Paraguay
by: Jessica Figueredo, et al.
Published: (2024-01-01)

Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication
by: Rameez Hassan Pirzada, et al.
Published: (2021-04-01)

COVID-19 Mortality and Therapeutics in Nebraska and Southwest Iowa during Early Pandemic
by: Christopher J. Destache, et al.
Published: (2022-06-01)

Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study
by: Valentina Giudice, et al.
Published: (2020-06-01)

Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview
by: Haleh Rezaee, et al.
Published: (2021-02-01)

The journey of remdesivir: from Ebola to COVID-19
by: Joe Pardo, et al.
Published: (2020-05-01)

Treatment options used in COVID-19 Disease: Steroids, anticoagulants, remdesivir and/or antibiotics – Which worked better or combo was the right choice?
by: Shital Patil, et al.
Published: (2023-01-01)

Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure
by: Benjamin Seeliger, et al.
Published: (2021-01-01)

Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System
by: Courtney M. Barkoff, et al.
Published: (2020-12-01)

FAVIPIRAVIR AND DEXAMETHASONE IN MANAGEMENT OF SARS-COV2 INFECTION
by: M. Latief, et al.
Published: (2021-05-01)

New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine
by: Davide Gentile, et al.
Published: (2020-08-01)

An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease
by: Mulaw Belete T
Published: (2020-12-01)